Angiolink Corporation

company

About

Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$10.60M
Industries
Biotechnology,Health Care,Innovation Management,Medical,Medical Device
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$24.20M
Angiolink Corporation has raised a total of $24.20M in funding over 2 rounds. Their latest funding was raised on Sep 10, 2003 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 10, 2003 Series B $13.60M 1 Detail
Sep 17, 2002 Series A $10.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Angiolink Corporation is funded by 1 investors. Boston Financial & Equity Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Financial & Equity Corporation Series B